Beta Drugs Ltd

NSE: BETA · BSE: 531481 · Pharmaceuticals & Biotechnology · 8 announcements

Share price: ₹2,098.70
Market cap: ₹2,327 Cr
Revenue (annual): ₹384.8 Cr
Net profit (annual): ₹41.48 Cr
P/E (TTM): 51.0×Sector 50.4×
Promoter holding: 59.10%-5.53% QoQ
FII holding: 1.02%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3 Management Change 1 Financial Results 1 Business Update 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

22 Sep 2026 09:00 IST NSE

Business Update

Beta Drugs Business Update

Beta Drugs secured Azerbaijani regulatory approvals for its oncology portfolio across multiple dosage forms. The company targets Azerbaijan commercialisation during the current financial year.

Read the filing ↗